Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Sarcopenia 2Prostatic Neoplasms 2Obesity 2Melanoma 2Malnutrition 2Colorectal Neoplasms 2Breast Carcinoma In Situ 2Wound Infection 1Weight Loss 1Surgical Wound Infection 1Skin Neoplasms 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Postoperative Complications 1Polycystic Ovary Syndrome 1Phagocyte Bactericidal Dysfunction 1Pain 1Paget's Disease, Mammary 1Osteoarthritis 1Olfaction Disorders 1Neoplasms 1Neoplasm, Residual 1Mandibular Neoplasms 1Lymphoma, Follicular 1Lipid Metabolism Disorders 1Huntington Disease 1Fatigue 1Diabetes Mellitus 1

Interventions

Exercise 6Diet 6Octreotide 3Metformin 3Caloric Restriction 3Diet, Carbohydrate-Restricted 2Cognitive Behavioral Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1TOPS 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sampling Studies 1Ritonavir 1Resistance Training 1Quality of Life 1Psychology, Positive 1Palonosetron 1Palliative Care 1Olanzapine 1Nutritionists 1Nutritional Status 1Nutrition Assessment 1Methods 1Melatonin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Weight Loss × Docosahexaenoic Acids × Clear all
NCT02101970 2022-01-24

Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

University of Kansas Medical Center

Phase NA Completed
46 enrolled
Breast

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡